Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

269
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
269
Ovarian Cycle01:27

Ovarian Cycle

940
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
940
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

391
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
391
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

311
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
311
Birth Control Methods01:22

Birth Control Methods

167
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
167

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Optimal patient profile for ofatumumab treatment: analysis of Russian data from the Phase 3 study].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2024
Same author

[A role of cerebrovascular diseases in the progression of multiple sclerosis].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2024
Same author

[Multiple sclerosis and melanoma].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2023
Same author

[The development of multiple sclerosis over the age of 50].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2023
Same author

[Changes in venous circulation in patients with multiple sclerosis].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2023
Same author

[Toxoplasmosis in the practice of a neurologist].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2023
Same journal

[The role of the cerebellum in the coordination of brain activity and the development of autism spectrum disorders].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same journal

[A clinical case of anxiety-hypochondriacal depression with extensive somatized symptoms in the elderly].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same journal

[De novo variant in the ATP2B2 gene as a cause of neuropsychiatric developmental disorder].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same journal

[Electroencephalographic predictors of olfactory stimulus discrimination in COVID-19 survivors].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same journal

[Effect of long-term carbamazepine therapy on bone metabolism in women with epilepsy].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same journal

[Glial-derived neurotrophic factor and neuropsychological status in COVID-19 survivors].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

[Hormonal contraception methods and multiple sclerosis].

N Y Lashch1, A A Ashikhmina1, M I Kislaya1

  • 1Pirogov Russian National Research Medical University (Pirogov University), Moscow, Russia.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|February 11, 2025
PubMed
Summary
This summary is machine-generated.

For women with multiple sclerosis (MS), estrogen-containing oral contraceptives offer effective pregnancy prevention. These contraceptives may also positively impact the course of MS, a condition affecting women more than men.

Keywords:
combined oral contraceptivescontraceptive methodsestrogenmultiple sclerosispregnancyyoung women

More Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Related Experiment Videos

Last Updated: Jun 23, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Area of Science:

  • Neurology
  • Immunology
  • Endocrinology

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease disproportionately affecting women, particularly those aged up to 35.
  • Many women with MS are of reproductive age, requiring safe and effective contraception and seeking to minimize abortion rates.
  • Current MS treatment hypotheses suggest estrogen may play a role in reducing disease relapses and progression.

Purpose of the Study:

  • To evaluate the safety, convenience, and efficacy of contraceptive options for women with multiple sclerosis.
  • To explore the potential benefits of estrogen-containing oral contraceptives in managing MS course alongside pregnancy prevention.

Main Methods:

  • Review of existing literature on contraceptive use in women with multiple sclerosis.
  • Analysis of the pharmacological properties of estrogen-containing oral contraceptives.
  • Consideration of current hypotheses regarding estrogen's role in multiple sclerosis pathogenesis and treatment.

Main Results:

  • Estrogen-containing oral contraceptives provide reliable protection against pregnancy.
  • The use of estrogen in oral contraceptives aligns with emerging hypotheses about its potential positive impact on MS relapses and progression.

Conclusions:

  • Estrogen-containing oral contraceptives represent a viable and potentially beneficial strategy for women with MS.
  • This contraceptive approach addresses both the need for effective family planning and the potential for disease modification in multiple sclerosis.